Who is sponsoring TFXSHF?

TFXSHF is sponsored by Guangzhou University of Traditional Chinese Medicine.

What condition does TFXSHF study?

TFXSHF studies Stroke, Complication.

What drugs are being tested in TFXSHF?

Interventions: Tongfu capsules, The Placebo of Tongfu capsules.

Last reviewed 2020-09-04 · How we verify

Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia (TFXSHF)

NCT04275219 Phase 4 UNKNOWN

Stroke-associated pneumonia (SAP) is the major complication of acute intracerebral haemorrhage (AICH), leads to poor clinical outcomes and increases the financial burden on the medical system. Prophylactic antibiotics do not reduce the mortality rate of SAP. The Tong-Fu-Xing-Shen herbal formula (TFXS) was shown to be effective for the prevention and treatment SAP in a previous clinical trial. To clarify whether TFXS is effective and safe for the treatment of SAP and affects the immunological mechanism of the "brain-gut-lung" pathway of SAP, the investigators designed this study.

Details

Lead sponsor	Guangzhou University of Traditional Chinese Medicine
Phase	Phase 4
Status	UNKNOWN
Enrolment	218
Start date	2019-03-15
Completion	2021-12

Conditions

Stroke
Complication

Interventions

Tongfu capsules
The Placebo of Tongfu capsules

Primary outcomes

the all-cause mortality rate — 90±7 days
Any cause of death
the mortality of stroke associated pneumonia — 90±7 days
the death of stroke associated pneumonia

Countries

China